🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A potential application of therapeutic drug monitoring is to predict effica...
Status
Unknown
Location
Sint Maartenskliniek
Start Date
2020-07-31
Trial ID
NCT04251741
Treatments Being Tested
The study investigators are interested in learning more about how drugs, th...
Status
Recruiting
Location
Phoenix Children's Hospital
Start Date
2020-03-05
Trial ID
NCT04278404
Primary Objective: To describe the safety and tolerability, including labo...
Status
Completed
Location
Investigational Site Number 392001
Start Date
2015-05
Trial ID
NCT02404558
Treatments Being Tested
Primary Objective: To assess, in the same study, the safety of sarilumab a...
Status
Completed
Location
Investigational Site Number 840152
Start Date
2013-03
Trial ID
NCT01768572
REMAP-CAP is a randomised, embedded, multifactorial, adaptive platform tria...
Status
Recruiting
Location
University of Florida
Start Date
2016-04-11
Trial ID
NCT02735707
Treatments Being Tested
The purpose of this study is to learn how different types of medicines may ...
Status
Completed
Location
Pfizer
Start Date
2024-05-15
Trial ID
NCT06418529
Treatments Being Tested
With this study the investigators aim to assess if drug metabolism changes ...
Status
Terminated
Location
Hospital South West Jutland
Start Date
2021-05-25
Trial ID
NCT04842981
Treatments Being Tested
Approximately, 40 to 50% of patients with rheumatoid arthritis (RA), the mo...
Status
Recruiting
Location
Hôpitaux Universitaires de Strasbourg
Start Date
2016-03-30
Trial ID
NCT02714634
The main purpose of this study is to: * Learn about the safety of ubamatam...
Status
Recruiting
Location
University of Alabama_6th Ave
Start Date
2018-05-21
Trial ID
NCT03564340
Treatments Being Tested
1. Investigate the possible effects of interleukin-6 receptor antagonists s...
Status
Completed
Location
AssiutU
Start Date
2022-02-01
Trial ID
NCT05367882
Treatments Being Tested